Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 12 Jan 2023 |
2 | Reply to Exam Report (MIS-R) | 14 Jul 2023 |
3 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 06 Aug 2023 |
4 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 08 Aug 2023 |
5 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 18 Feb 2024 |
6 | Journal Copy | 18 Mar 2024 |
7 | Certificate | 09 Jul 2024 |
1 | EXAMINATION REPORT | 15450826 | 19 Jun 2023 | |
2 | Hearing Notice (Show Cause) | 15725599 | 28 Jul 2023 | |
3 | Hearing Notice (Show Cause) | 16194059 | 05 Oct 2023 | |
4 | Tribunal Accepted Notice for : 5760696 | 16839325 | 6394999 | 15 Dec 2023 |
The application for Senumin was made on 12 January 2023.
The trademark applicant for Senumin is SENORES PHARMACEUTICALS.
Senumin is applied in class(es) 5.
Application for Senumin is on Registered stage.
Application Id allotted to Senumin is 5760696.
Trademark agent or attorney for the application is Mohit Tantia.
Senumin filed with the Intellectual property office as a WORD.